Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $28,132 | 1,171 | 99.8% |
| Education | $52.78 | 7 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,942 | 179 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,716 | 71 | $0 (2024) |
| ABBVIE INC. | $3,136 | 142 | $0 (2024) |
| Allergan, Inc. | $2,107 | 80 | $0 (2020) |
| Lilly USA, LLC | $1,823 | 106 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,103 | 72 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,056 | 70 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $949.46 | 47 | $0 (2024) |
| PFIZER INC. | $936.32 | 48 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $845.76 | 36 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,680 | 262 | ABBVIE INC. ($774.49) |
| 2023 | $5,512 | 286 | AbbVie Inc. ($807.13) |
| 2022 | $4,569 | 211 | ABBVIE INC. ($727.69) |
| 2021 | $3,196 | 49 | AbbVie Inc. ($826.27) |
| 2020 | $2,069 | 62 | Allergan, Inc. ($712.76) |
| 2019 | $3,445 | 164 | Allergan Inc. ($886.92) |
| 2018 | $2,217 | 96 | AstraZeneca Pharmaceuticals LP ($542.76) |
| 2017 | $1,496 | 48 | AstraZeneca Pharmaceuticals LP ($369.47) |
All Payment Transactions
1,178 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/17/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Analgesic | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: DIABETES | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: PAIN | ||||||
| 12/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Diabetes Care | ||||||
| 12/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $1.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: Cardio-renal | ||||||
| 12/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Obesity | ||||||
| 12/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Bone Health | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.38 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Oncology | ||||||
| 11/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: VACCINES | ||||||
| 11/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: Cardio-renal | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 537 | 778 | $103,092 | $43,810 |
| 2022 | 9 | 594 | 896 | $109,190 | $49,151 |
| 2021 | 14 | 655 | 1,067 | $117,708 | $54,391 |
| 2020 | 15 | 819 | 1,180 | $123,605 | $48,405 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 193 | 325 | $41,127 | $16,745 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 137 | 192 | $33,896 | $13,686 | 40.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 64 | 64 | $17,664 | $7,687 | 43.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 31 | 31 | $3,100 | $2,350 | 75.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $2,460 | $986.94 | 40.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 49 | 103 | $3,193 | $980.56 | 30.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $1,176 | $973.42 | 82.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $476.00 | $400.82 | 84.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 198 | 339 | $38,559 | $17,385 | 45.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 136 | 229 | $37,327 | $17,209 | 46.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 62 | 62 | $17,112 | $7,590 | 44.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 37 | 37 | $3,626 | $2,529 | 69.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $5,084 | $1,530 | 30.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 45 | 45 | $1,569 | $1,229 | 78.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 54 | 101 | $3,131 | $967.94 | 30.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $442.00 | $357.03 | 80.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 39 | $2,340 | $352.55 | 15.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 164 | 291 | $47,433 | $22,849 | 48.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 192 | 310 | $33,790 | $17,287 | 51.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 29 | 29 | $8,004 | $3,625 | 45.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 13 | 13 | $5,304 | $2,068 | 39.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 26 | 30 | $3,270 | $1,696 | 51.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 25 | 25 | $2,450 | $1,632 | 66.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $3,280 | $1,222 | 37.3% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 54 | 98 | $3,038 | $951.58 | 31.3% |
About Dr. Gregory Spangler, MD
Dr. Gregory Spangler, MD is a Family Medicine healthcare provider based in Kokomo, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780606046.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Spangler, MD has received a total of $28,185 in payments from pharmaceutical and medical device companies, with $5,680 received in 2024. These payments were reported across 1,178 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($28,132).
As a Medicare-enrolled provider, Spangler has provided services to 2,605 Medicare beneficiaries, totaling 3,921 services with total Medicare billing of $195,757. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Geriatric Medicine, Geriatric Medicine
- Location Kokomo, IN
- Active Since 07/24/2006
- Last Updated 11/27/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1780606046
Products in Payments
- VRAYLAR (Drug) $3,101
- FARXIGA (Drug) $2,525
- Kerendia (Drug) $1,103
- UBRELVY (Drug) $1,057
- Wegovy (Drug) $1,045
- JARDIANCE (Drug) $915.79
- MOUNJARO (Drug) $813.58
- Saxenda (Drug) $712.58
- NURTEC ODT (Drug) $659.37
- CAPLYTA (Drug) $559.68
- Rybelsus (Drug) $559.18
- Ozempic (Drug) $544.48
- QELBREE (Drug) $540.13
- NEXLIZET (Drug) $499.93
- TRELEGY ELLIPTA (Drug) $455.72
- Qelbree (Drug) $409.33
- LINZESS (Drug) $394.73
- RYBELSUS (Drug) $392.02
- ARISTADA (Drug) $390.05
- BREZTRI (Drug) $356.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kokomo
Victoria Moyer, Md, MD
Family Medicine — Payments: $240,848
Sheryar Sarwar, Md, MD
Family Medicine — Payments: $23,179
Hardik Shah, Md, MD
Family Medicine — Payments: $9,649
Josephine Lilla, M.d, M.D
Family Medicine — Payments: $8,884
Sondi Beeler, Md, MD
Family Medicine — Payments: $8,512
Nicole Lockwood, Md, MD
Family Medicine — Payments: $8,241